Harald Schmalenberg
Harald Schmalenberg publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Esophageal Cancer Research and Treatment and Gastrointestinal Tumor Research and Treatment.
- World rank
- #1,183,924 of 7,710,434 ranked researchers
- Rank in Germany
- #58,258 of 364,343
- Works
- 89
- Citations
- 8.7k
- Citations per work
- 97.2
What does Harald Schmalenberg research?
Harald Schmalenberg's work is mostly in Medicine (77%), Biochemistry, Genetics and Molecular Biology (3%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences6977.1%
- Medicine6977.1%
- Everything else1819.8%
- Life Sciences33.1%
- 1Pulmonary and Respiratory Medicine28% of their works
- 2Oncology18% of their works
- 3Surgery16% of their works
- 4Gastroenterology10% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Molecular Biology3% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Esophageal Cancer Research and Treatment
- Gastrointestinal Tumor Research and Treatment
- Colorectal Cancer Treatments and Studies
- Metastasis and carcinoma case studies
- Clinical practice guidelines implementation
- Lung Cancer Treatments and Mutations
- Melanoma and MAPK Pathways
Which keywords describe Harald Schmalenberg's research?
The keywords of their largest research topics: Endoscopic Resection, Chemotherapy, Gastric Cancer, Molecular Characterization, Esophageal Carcinoma, Preoperative Chemoradiotherapy, Imatinib Mesylate and Sunitinib.
- MAP Kinase
- Targeted Therapy
- EGFR Mutations
- Metastatic Carcinomas
- KRAS Mutations
- Sunitinib
- Preoperative Chemoradiotherapy
- Molecular Characterization
- Chemotherapy
- Endoscopic Resection
- Gastric Cancer
- Esophageal Carcinoma
- Imatinib Mesylate
- Cetuximab
- Lung Tumors
- Clinical Guidelines
- Guideline Development
- BRAF gene
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Endoscopic Resection782 topics
- Chemotherapy702 topics
- Gastric Cancer481 topic
- Molecular Characterization481 topic
- Esophageal Carcinoma301 topic
- Preoperative Chemoradiotherapy301 topic
- Imatinib Mesylate251 topic
- Sunitinib251 topic
- Cetuximab221 topic
- KRAS Mutations221 topic
- Lung Tumors121 topic
- Metastatic Carcinomas121 topic
- Clinical Guidelines81 topic
- EGFR Mutations81 topic
- Guideline Development81 topic
- Targeted Therapy81 topic
- BRAF gene71 topic
- MAP Kinase71 topic
Where does Harald Schmalenberg work?
Harald Schmalenberg's main affiliation in the publication record is Krankenhaus Nordwest, Germany.
How many publications and citations does Harald Schmalenberg have?
OpenAlex counts 89 works and 8,651 citations for Harald Schmalenberg, an h-index of 24, ranking #1,183,924 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Harald Schmalenberg. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.